Tairāwhiti-based medicinal cannabis company Rua Bioscience Limited has posted an expected loss for the financial year as it continues expansion plans. Over the financial year, Rua signed supply and distribution agreements targeting growth markets in Australasia, Poland and the Czech Republic; expanded supply partnerships in Australia and Europe; and successfully launched product into Germany, generating their first international sales. As the only New Zealand-based medicinal cannabis company with an explicit focus on delivering social impact, Rua's loss before tax for the year to June 30, 2023, was $5.

https://www.gisborneherald.co.nz/news/rua-bioscience-limited-pushing-on-with-expansion-plans

#gisborneherald